CD274 and neoplasm: When PD‐L1 on tumor cells interacts with PD‐1 on T cells, it activates downstream signaling pathways that inhibit T‐cell signaling and function, suppress T‐cell proliferation and activation, and diminish immune‐stimulating factors, ultimately leading to immune evasion [11].